- American City Business Journals•3 days agoHere’s where a Pinellas billionaire and top donor to Church of Scientology is putting his investment dollars
Robert Duggan, one of the most influential executives in the biopharmaceutical field, has bought a 15.4 percent stake in Pulse Biosciences Inc., a Burlingame, California medical technology company. Duggan, who relocated to the Tampa Bay area after selling biotech firm Pharmacyclics to AbbVie in May 2015 for $21 billion, controls nearly 2.2 million shares of Pulse Biosciences (PLSE), with most of the stock purchased between Dec. 7 and Feb. 9, a Feb. 21 filing with the U.S. Securities and Exchange Commission said. Duggan has a net worth of $2.6 billion, according to Forbes, which included him on the 2016 list of the 400 wealthiest people in the United States.
- American City Business Journals•12 days ago
Drug company Pharmacyclics made the highest amount of non-research payments out of the more than $9 million in payments received by 25 Chicago-area doctors in 2015. Sunnyvale, California-based Pharmacyclics, ...
- Motley Fool•9 months ago
A key presentation at ASCO next month for Stemcentrix's Rova-T could cause shares to pop.
PCYC : Summary for Pharmacyclics, Inc. - Yahoo Finance
Pharmacyclics, Inc. (PCYC)
NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
At close: 2:59PM EST
|Day's Range||0.00 - 0.00|
|52 Week Range|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|